Owner Pfizer Inc.

Inventors Van Der Graaf, Pieter Hadewijn; Naylor, Alasdair Mark; Wayman, Christopher Peter; Street, Stephen Derek Albert; Tang, Kim-Wah; Russell, Rachel Jane

Agent Spruson & Ferguson

Pub. Number AU-B-2003201471

PCT Number PCT/IB03/00140

PCT Pub. Number WO2003/064402

Priority 0202282.0 31.01.02 GB

Filing date 20 January 2003

Wipo publication date 2 September 2003

Acceptance publication date 26 March 2009

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 38/11 (2006.01) Medicinal preparations containing peptides

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 295/22 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 295/26 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07K 14/72 (2006.01) Peptides having more than 20 amino acids